MedAssets 11th Annual Technology & Innovation Forum Gives Healthcare Providers Hands-on Access to Latest Technologies and Clinical Advancements

Delivers Value to Organizations Seeking to Better Manage Costs While Improving Care Delivery

ATLANTA--(BUSINESS WIRE)--Reflecting its continued focus on helping healthcare organizations reduce costs through technological innovation, MedAssets (NASDAQ: MDAS) recently held its 11^th annual Technology & Innovation Forum. Approximately 70 suppliers of high-quality medical products and services showcased the newest healthcare and clinical technologies to more than 400 MedAssets provider clients who, in turn, offered valuable, real-world feedback on the supplier offerings.

“Not only were we able to glimpse the future of healthcare innovation, but we also had the opportunity to actively engage suppliers and influence product development.”

During the day-long event, healthcare provider attendees—all of whom are key decision-makers for leading healthcare organizations—were introduced to a variety of innovative solutions designed to enhance care delivery, improve clinical performance, as well as contain costs.

The Technology & Innovation Forum was held in Dallas, Texas, in conjunction with the MedAssets Business and Technology Forum, a broader event designed to bring together suppliers and healthcare providers for professional networking, education and facilitation of new product development.

Commitment to Innovation

In a survey conducted at the event, the majority of attendees reported that the Technology & Innovation Forum directly benefits their facilities by providing access to new products and services.

“MedAssets Technology & Innovation Forum was a key event for Ochsner Health System,” said Grant Walker, vice president, Supply Chain, Ochsner Health System. “Not only were we able to glimpse the future of healthcare innovation, but we also had the opportunity to actively engage suppliers and influence product development.”

Participants were invited to exhibit at the forum based on several criteria, including degree of technological advancement of the product or service offering, as well as the product or service’s ability to reduce supply chain costs and/or improve care delivery. As part of MedAssets client-led sourcing structure, suppliers receiving a high ranking from event attendees and meeting MedAssets eligibility guidelines will continue through the sourcing process for consideration to be added to the MedAssets contract portfolio, which is comprised of more than 1,800 companies.

“In an environment where healthcare organizations continue to face rising costs and lower reimbursements, the need for cost-effective healthcare technologies and services that support high-quality care will continue to increase,” said Les Popiolek, senior vice president, Sourcing, MedAssets. “As the largest provider of comprehensive cost management solutions and a leading group purchasing organization, MedAssets is committed to fostering collaboration between suppliers and clients so that we can identify and incorporate into our contract portfolio the technologies, products and services to that will provide our clients with optimal value.”

About MedAssets

MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve their financial strength by implementing revenue cycle, spend and clinical resource management solutions that help capture revenue, control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency. MedAssets serves more than 4,200 hospitals and 100,000 non-acute healthcare providers. The company currently manages $48 billion in supply spend and touches over $340 billion in gross patient revenue annually through its revenue cycle solutions. For more information, go to www.medassets.com.

MDAS/B